Related Experiment Video
Updated: Apr 18, 2026

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
Published on: March 30, 2018
Stem cells for the treatment of musculoskeletal pain
Luminita Labusca1, Florin Zugun-Eloae1, Kaveh Mashayekhi1
1Luminita Labusca, Department of Orthopedic Surgery, University Hospital Saint Spiridon, 700111 Iasi, Romania.
Abstract:
Musculoskeletal-related pain is one of the most disabling health conditions affecting more than one third of the adult population worldwide. Pain from various mechanisms and origins is currently underdiagnosed and undertreated. The complexity of molecular mechanisms correlating pain and the progression of musculoskeletal diseases is not yet fully understood. Molecular biomarkers for objective evaluation and treatment follow-up are needed as a step towards targeted treatment of pain as a symptom or as a disease. Stem cell therapy is already under investigation for the treatment of different types of musculoskeletal-related pain. Mesenchymal stem cell-based therapies are already being tested in various clinical trials that use musculoskeletal system-related pain as the primary or secondary endpoint. Genetically engineered stem cells, as well as induced pluripotent stem cells, offer promising novel perspectives for pain treatment. It is possible that a more focused approach and reassessment of therapeutic goals will contribute to the overall efficacy, as well as to the clinical acceptance of regenerative medicine therapies. This article briefly describes the principal types of musculoskeletal-related pain and reviews the stem cell-based therapies that have been specifically designed for its treatment.
Insights
Musculoskeletal pain affects over a third of adults globally and is often undertreated. Stem cell therapies, including mesenchymal stem cells, show promise for managing this widespread condition.
Area of Science:
- Regenerative Medicine
- Pain Management
- Biomarkers
Background:
- Musculoskeletal pain is a leading cause of disability worldwide, affecting over 33% of adults.
- Current understanding of pain mechanisms in musculoskeletal diseases is incomplete, leading to underdiagnosis and undertreatment.
- Objective molecular biomarkers are needed for evaluating pain and treatment efficacy.
Purpose of the Study:
- To review current stem cell-based therapies for musculoskeletal pain.
- To explore novel perspectives in regenerative medicine for pain treatment.
- To highlight the need for targeted therapeutic approaches.
Main Methods:
- Review of existing literature on stem cell therapies for musculoskeletal pain.
- Analysis of clinical trials involving mesenchymal stem cells for pain endpoints.
- Discussion of genetically engineered and induced pluripotent stem cells in pain management.
Main Results:
- Stem cell therapy, particularly using mesenchymal stem cells, is under active investigation for musculoskeletal pain.
- Various clinical trials are evaluating stem cell therapies with pain as a primary or secondary outcome.
- Genetically engineered and induced pluripotent stem cells represent emerging therapeutic avenues.
Conclusions:
- Stem cell-based regenerative medicine offers promising strategies for treating musculoskeletal pain.
- Further research and a focused therapeutic approach are crucial for clinical acceptance and efficacy.
- Development of molecular biomarkers will aid in objective evaluation and personalized treatment of pain.
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
iPS Cell Differentiation
Stem Cell Culture
Satellite Stem Cells and Muscular Dystrophy
Embryonic Stem Cells

